Pharmaceutical Business review

Hi-Tech acquires Cormax brand rights from Watson

Cormax is a branded version of clobetasol propionate topical solution 0.05%.

Cormax is indicated for the treatment of dermatoses of the scalp.

Hi-Tech Pharmacal president and CEO David Seltzer said since the company will manufacture Cormax for its subsidiary, ECR Pharmaceuticals, it anticipates the product will generate high margins.

"We are pleased to add another well-recognized brand to the ECR portfolio of branded products," Seltzer added.